Nine-Month Continuous Fremanezumab Prophylaxis on the Response to Triptans and Also on the Incidence of Triggers, Hypersensitivity and Prodromal Symptoms of Patients with High-Frequency Episodic Migraine

Nine-Month Continuous Fremanezumab Prophylaxis on the Response to Triptans and Also on the Incidence of Triggers, Hypersensitivity and Prodromal Symptoms of Patients with High-Frequency Episodic Migraine

<b>Objective:</b> To investigate whether the incidence of triggers, prodromal symptoms, hypersensitivity symptoms accompanying headache and responses to triptans were modified during a continuous 9-month fremanezumab therapy for migraine prophylaxis. <b>Patients and methods:</b&...

Full description

Bibliographic Details
Main Authors: Emmanouil V. Dermitzakis, Michail Vikelis, Georgia Xiromerisiou, Dimitrios Rallis, Panagiotis Soldatos, Pantelis Litsardopoulos, Dimitrios Rikos, Andreas A. Argyriou
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:Journal of Clinical Medicine
Subjects:
fremanezumab
effects
response to triptans
hypersensitivity symptoms
prodromal symptoms
triggers
Online Access:https://www.mdpi.com/2077-0383/13/2/386

Similar Items

Similar Items